ロード中...
NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes
Increasing evidence suggests that NODs are involved in liver diseases; however, the underlying mechanisms remain obscure. In the present study, we analyzed the effect of NOD1 agonist pretreatment on acute liver failure induced by lipopolysaccharide (LPS) in D-galactosamine (D-GalN)-sensitized mice....
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969647/ https://ncbi.nlm.nih.gov/pubmed/33746949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.603192 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|